Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $122,060 | $85,239 | $41,143 | $90,545 |
| % Growth | 43.2% | 107.2% | -54.6% | – |
| Cost of Goods Sold | $0 | $0 | $27,432 | $0 |
| Gross Profit | $122,060 | $85,239 | $13,711 | $90,545 |
| % Margin | 100% | 100% | 33.3% | 100% |
| R&D Expenses | $22,468 | $23,373 | $27,432 | $25,391 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $21,908 | $16,795 | $0 | $33,590 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,200 | -$250 | $15,387 | $73 |
| Operating Expenses | $46,576 | $39,918 | $42,819 | $59,054 |
| Operating Income | $75,484 | $45,321 | -$29,108 | $31,491 |
| % Margin | 61.8% | 53.2% | -70.7% | 34.8% |
| Other Income/Exp. Net | -$7,464 | -$7,499 | -$7,164 | -$7,496 |
| Pre-Tax Income | $68,020 | $37,822 | -$36,272 | $23,995 |
| Tax Expense | $27,940 | $14,223 | $1,114 | $21,739 |
| Net Income | $40,080 | $23,599 | -$37,386 | $2,256 |
| % Margin | 32.8% | 27.7% | -90.9% | 2.5% |
| EPS | 0.25 | 0.15 | -0.23 | 0.014 |
| % Growth | 66.7% | 165.2% | -1,731.2% | – |
| EPS Diluted | 0.23 | 0.14 | -0.23 | 0.014 |
| Weighted Avg Shares Out | 162,215 | 161,723 | 160,974 | 159,895 |
| Weighted Avg Shares Out Dil | 177,764 | 161,723 | 160,974 | 160,419 |
| Supplemental Information | – | – | – | – |
| Interest Income | $930 | $818 | $869 | $778 |
| Interest Expense | $8,434 | $8,356 | $8,070 | $8,914 |
| Depreciation & Amortization | $475 | $467 | $479 | $485 |
| EBITDA | $76,929 | $46,645 | -$10,070 | $33,394 |
| % Margin | 63% | 54.7% | -24.5% | 36.9% |